Pharmaceutical companies have built a business model around treating mental illness with pills, and this film asks whether that model has gone too far. It looks at the explosion of diagnoses for conditions like anxiety and bipolar disorder, and at how drug marketing, psychiatric practice, and insurance incentives have combined to push medication as the default answer for emotional distress. Doctors, patients, and critics of the industry describe how diagnostic categories have widened over the decades, making more people eligible for prescriptions than ever before. The film raises questions about side effects, long-term dependency, and whether some patients are medicated for problems that talk therapy or lifestyle changes might address instead. Rather than dismissing psychiatric medicine outright, it focuses on the specific mechanics of an industry with a direct financial stake in more diagnoses and more prescriptions, and lets that financial incentive sit uncomfortably next to the clinical language of care.